Skip to main content
TipRanks
Go Ultimate75% OFF

Herwig Janssen Insider Profile

4 Followers

Herwig Janssen, Director at Tryptamine Therapeutics, holds 39.30M shares in Tryptamine Therapeutics (Ticker: AU:ENP).

Herwig Janssen's Trading History

ENP
Tryptamine Therapeutics
Oct 14, 2026DirectorUninformative Buy25.00KAU$1.10M
AU:ENP
Insider Shares: 39.30M (240.75%)

Herwig Janssen has not reported any informative transactions for AU:ENP, therefore, performance cannot be measured.

DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Oct 14, 2026Uninformative BuyAU$25.00K623,441AU$0.04――
Aug 07, 2026Uninformative BuyAU$25.00K766,871AU$0.03――
Apr 20, 2026Uninformative BuyAU$24.98K726,195AU$0.03――
Jan 16, 2026Uninformative BuyAU$64.11K1,931,012AU$0.03――

You May Also Like

Herwig Janssen insider profile FAQ

What stocks does Herwig Janssen hold?
Herwig Janssen holds: AU:ENP stocks.
What was Herwig Janssen’s latest transaction?
Herwig Janssen’s latest transaction was an Uninformative Buy of AU$25.00K.
What is Herwig Janssen's role in Tryptamine Therapeutics?
Herwig Janssen's role in Tryptamine Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.